Francis Knuettel II - Sep 10, 2024 Form 4 Insider Report for Chromocell Therapeutics Corp (CHRO)

Signature
/s/ Francis Knuettel II
Stock symbol
CHRO
Transactions as of
Sep 10, 2024
Transactions value $
$10,955
Form type
4
Date filed
9/12/2024, 05:35 PM
Previous filing
Jul 2, 2024
Next filing
Sep 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRO Common Stock Purchase $5.79K +6.5K +1.23% $0.89 537K Sep 10, 2024 By Lara Knuettel Revocable Trust F1
transaction CHRO Common Stock Purchase $5.17K +5.5K +1.02% $0.94 543K Sep 11, 2024 By Lara Knuettel Revocable Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction is being reported to reflect the purchase of these shares by the Lara Knuettel Revocable Trust, of which the Reporting Person is co-trustee and has individual dispositive power. This sale price represents the weighted average sale price of the shares purchased ranging from $0.80 to $0.92 per share, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
F2 This transaction is being reported to reflect the purchase of these shares by the Lara Knuettel Revocable Trust, of which the Reporting Person is co-trustee and has individual dispositive power. This sale price represents the weighted average sale price of the shares purchased ranging from $0.89 to $0.98 per share, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.